Embracing Future Holdings Limited (8YY.SI)

Healthcare | Medical Diagnostics Research
Income Statement (Quarterly) 2026-05-06 2025-06-30 2025-03-31
Revenue 1,757,000 878,500 878,500
Cost of Revenue 1,261,000 630,500 630,500
Gross Profit 496,000 248,000 248,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 692,000 346,000 346,000
Operating Expenses 692,000 346,000 346,000
Operating Income -196,000 -98,000 -98,000
Interest Expense 6,000 3,000 3,000
Income Before Tax -614,000 -307,000 -307,000
Income Tax Expense 11,000 5,500 5,500
Net Income -625,000 -312,500 -312,500
Per Share
EPS 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31
Revenue 784,000
Cost of Revenue 597,000
Gross Profit 187,000
Operating Expenses
R&D Expenses 0
SG&A Expenses 1,953,000
Operating Expenses 1,889,000
Operating Income -1,702,000
Interest Expense 39,000
Income Before Tax -3,187,000
Income Tax Expense 5,000
Net Income -3,434,000
Per Share
EPS 0.00
EPS Diluted 0.00
Balance Sheet (Quarterly)